These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. The Impact of Collagenase Clostridium histolyticum Introduction on Dupuytren Treatment Patterns in the United States. Zhao JZ; Hadley S; Floyd E; Earp BE; Blazar PE J Hand Surg Am; 2016 Oct; 41(10):963-968. PubMed ID: 27546441 [TBL] [Abstract][Full Text] [Related]
66. The efficacy and safety of collagenase clostridium histolyticum in the treatment of patients with moderate Dupuytren's contracture. McGrouther DA; Jenkins A; Brown S; Gerber RA; Szczypa P; Cohen B Curr Med Res Opin; 2014 Apr; 30(4):733-9. PubMed ID: 24397625 [TBL] [Abstract][Full Text] [Related]
67. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. Badalamente MA; Hurst LC; Hentz VR J Hand Surg Am; 2002 Sep; 27(5):788-98. PubMed ID: 12239666 [TBL] [Abstract][Full Text] [Related]
68. Development of Collagenase Treatment for Dupuytren Disease. Badalamente MA; Hurst LC Hand Clin; 2018 Aug; 34(3):345-349. PubMed ID: 30012294 [TBL] [Abstract][Full Text] [Related]
71. DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture. Räisänen MP; Karjalainen T; Göransson H; Reito A; Kautiainen H; Malmivaara A; Leppänen OV BMJ Open; 2018 Mar; 8(3):e019054. PubMed ID: 29599391 [TBL] [Abstract][Full Text] [Related]
72. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. Holzer LA; Holzer G N Engl J Med; 2009 Dec; 361(26):2579; author reply 2579-80. PubMed ID: 20050321 [No Abstract] [Full Text] [Related]
73. Pain Associated With Treatment of Dupuytren Contracture With Collagenase Clostridium histolyticum. Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P; Fikri-Benbrahim N; Franco-Ferrando N; Peimer CA J Hand Surg Am; 2017 Feb; 42(2):e109-e114. PubMed ID: 28160905 [TBL] [Abstract][Full Text] [Related]
74. Does collagenase injection disrupt or digest the Dupuytren's cord: a magnetic resonance imaging study. Crivello KM; Potter HG; Moon ES; Rancy SK; Wolfe SW J Hand Surg Eur Vol; 2016 Jul; 41(6):614-20. PubMed ID: 26768221 [TBL] [Abstract][Full Text] [Related]
75. [Treatment of Dupuytren's disease with collagenase Clostridium histolyticum]. Keller M; Arora R; Schmiedle G; Kastenberger T Orthopade; 2017 Apr; 46(4):321-327. PubMed ID: 28138723 [TBL] [Abstract][Full Text] [Related]
76. Efficacy and tolerability of Day 2 manipulation and local anaesthesia after collagenase injection in patients with Dupuytren's contracture. Manning CJ; Delaney R; Hayton MJ J Hand Surg Eur Vol; 2014 Jun; 39(5):466-71. PubMed ID: 23719171 [TBL] [Abstract][Full Text] [Related]
77. [Treatment of Dupuytren's disease with collagenase - a 1-year follow-up of 37 patients]. Binter A; Neuwirth M; Rab M Handchir Mikrochir Plast Chir; 2014 Dec; 46(6):355-60. PubMed ID: 25564949 [TBL] [Abstract][Full Text] [Related]
78. Minimally Invasive Treatments of Dupuytren Disease: An Overview. Yeo JH; Kim JY J Hand Surg Asian Pac Vol; 2021 Jun; 26(2):131-141. PubMed ID: 33928844 [TBL] [Abstract][Full Text] [Related]
79. Risk Factors for Long-Term Contracture Recurrence after Collagenase Injection for Dupuytren Disease: A Prospective Cohort Study. Eckerdal D; Lauritzson A; Åkesson A; Atroshi I Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979678 [TBL] [Abstract][Full Text] [Related]
80. Cost Comparison of Collagenase Clostridium Histolyticum and Fasciectomy for Treatment of Dupuytren's Contracture in the Australian Health System. Sefton AK; Smith BJ; Stewart DA J Hand Surg Asian Pac Vol; 2018 Sep; 23(3):336-341. PubMed ID: 30282551 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]